Join
Live feed
·
INSIDERFilingvia Quantisnow
Catalyst Pharmaceuticals Inc. logo

Chief Compliance/Legal Officer Elsbernd Brian converted options into 6,667 shares and covered exercise/tax liability with 2,623 shares, increasing direct ownership by 2% to 242,501 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CPRX· Catalyst Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPRX (Catalyst Pharmaceuticals Inc.) and more on Quantisnow.